SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Daniels Jon G

(Last) (First) (Middle)
12800 TUCKAHOE CREEK PARKWAY

(Street)
RICHMOND VA 23238

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
12/10/2014
3. Issuer Name and Ticker or Trading Symbol
CARMAX INC [ KMX ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
SVP, CAF
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 11,787 D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Options (Right to Buy)(1) (2) 04/07/2016 Common Stock 17,242 $11.43 D
Stock Options (Right to Buy)(1) (3) 04/06/2017 Common Stock 29,011 $25.39 D
Stock Options (Right to Buy)(1) (4) 04/05/2018 Common Stock 29,011 $32.69 D
Stock Options (Right to Buy)(1) (5) 04/10/2019 Common Stock 31,516 $31.76 D
Stock Options (Right to Buy)(1) (6) 04/15/2020 Common Stock 23,151 $42.68 D
Stock Options (Right to Buy)(1) (7) 04/09/2021 Common Stock 29,225 $44.96 D
Restricted Stock Units (8) (8)(9) Common Stock 3,273 $0 D
Restricted Stock Units (10) (9)(10) Common Stock 2,309 $0 D
Restricted Stock Units (11) (11)(12) Common Stock 2,324 $0 D
Explanation of Responses:
1. The stock options were granted in tandem with stock appreciation rights (SARS). Accordingly, the exercise of one results in the surrender to the Company of the other. The SARS become exercisable only following a change in control of the Company as set forth in the Company's 2002 Stock Incentive Plan, as amended and restated. Once exercisable, the SARS would entitle the Reporting Person to receive the cash value of the options in lieu of exercising the options.
2. The stock options vested in four equal installments on each of April 7, 2010, April 7, 2011, April 7, 2012 and April 7, 2013 and are now fully exercisable.
3. The stock options vested in four equal installments on each of April 6, 2011, April 6, 2012, April 6, 2013 and April 6, 2014 and are now fully exercisable.
4. The stock options became exercisable with respect to one-fourth of the underlying shares of Common Stock on each of April 5, 2012, April 5, 2013, and April 5, 2014 and become exercisable with respect to one-fourth of the underlying shares of Common Stock on April 5, 2015.
5. The stock options became exercisable with respect to one-fourth of the underlying shares of Common Stock on each of April 10, 2013 and April 10, 2014 and become exercisable with respect to one-fourth of the underlying shares of Common Stock on each of April 10, 2015 and April 10, 2016.
6. The stock options became exercisable with respect to one-fourth of the underlying shares of Common Stock on April 15, 2014, and become exercisable with respect to one-fourth of the underlying shares of Common Stock on each of April 15, 2015, April 15, 2016 and April 15, 2017.
7. The stock options become exercisable with respect to one-fourth of the underlying shares of Common Stock on each of April 9, 2015, April 9, 2016, April 9, 2017 and April 9, 2018.
8. The restricted stock units shall vest on April 10, 2015.
9. Shares of Company common stock will be issued to the Reporting Person following vesting of the restricted stock units, which are referred to by the Company as market stock units (the "MSUs"), in accordance with the terms of the Form of Notice of Market Stock Unit Grant filed as Exhibit 10.2 to the Company's Current Report on Form 8-K filed on December 23, 2011. The minimum number of shares of Company common stock that will be issued to the Reporting Person at payment is zero, and the maximum number of shares of Company common stock that will be issued at payment is two times the number of MSUs.
10. The restricted stock units shall vest on April 15, 2016.
11. The restricted stock units shall vest on April 9, 2017.
12. Shares of Company common stock will be issued to the Reporting Person following vesting of the restricted stock units, which are referred to by the Company as market stock units (the "MSUs"), in accordance with the terms of the Form of Notice of Market Stock Unit Grant filed as Exhibit 10.2 to the Company's Current Report on Form 8-K filed on January 31, 2014. The minimum number of shares of Company common stock that will be issued to the Reporting Person at payment is zero, and the maximum number of shares of Company common stock that will be issued at payment is two times the number of MSUs.
Remarks:
Exhibit List Exhibit 24.1 - Power of Attorney
Christine Carter, attorney-in-fact 12/18/2014
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.